Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Non Operating Income (2018 - 2025)

Rockwell Medical's Non Operating Income history spans 8 years, with the latest figure at -$156000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 34.18% year-over-year to -$156000.0; the TTM value through Dec 2025 reached -$623000.0, up 42.74%, while the annual FY2025 figure was -$623000.0, 42.74% up from the prior year.
  • Non Operating Income reached -$156000.0 in Q4 2025 per RMTI's latest filing, up from -$169000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$135000.0 in Q3 2023 to a low of -$965000.0 in Q4 2023.
  • Average Non Operating Income over 5 years is -$385850.0, with a median of -$371000.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: tumbled 902.82% in 2021, then soared 75.44% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$582000.0 in 2021, then soared by 31.96% to -$396000.0 in 2022, then plummeted by 143.69% to -$965000.0 in 2023, then skyrocketed by 75.44% to -$237000.0 in 2024, then surged by 34.18% to -$156000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Non Operating Income are -$156000.0 (Q4 2025), -$169000.0 (Q3 2025), and -$143000.0 (Q2 2025).